• Foghorn Therapeutics management to hold one-on-one investor meetings at H.C. Wainwright 4th Annual Bioconnect Investor Conference on May 19, 2026.
• Presentation at 2026 Stifel Virtual Targeted Oncology Forum set for May 20, 2026 at 11:00 a.m. EDT; CEO Adrian Gottschalk scheduled to present.
• CEO Adrian Gottschalk to present at TD Cowen 7th Annual Oncology Innovation Summit on May 26, 2026 at 8:30 a.m. EDT.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Foghorn Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605120700PRIMZONEFULLFEED9717736) on May 12, 2026, and is solely responsible for the information contained therein.